Safely Discontinue Antiviral Treatment in Patients With Chronic Hepatitis B
Status:
Recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
Multicenter, Open-label, Randomized Controlled Trial Chronic hepatitis B male and female
adults on antiviral treatment for hepatitis B, without cirrhosis who are currently HBV DNA
(-) and HBeAg (-) To evaluate the safety and efficacy of stopping long-term antiviral therapy
in chronic hepatitis B patients without cirrhosis who are currently HBV DNA (-) and HBeAg (-)